{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:01:32Z","timestamp":1789826492534,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.cbi.2022.110333","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T16:31:56Z","timestamp":1672417916000},"page":"110333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Exploring the repositioning of the amodiaquine as potential drug against visceral leishmaniasis: The in vitro effect against Leishmania infantum is associated with multiple mechanisms, involving mitochondria dysfunction, oxidative stress and loss of cell cycle control"],"prefix":"10.1016","volume":"371","author":[{"given":"Luciana M.Ribeiro","family":"Antinarelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9294-6597","authenticated-orcid":false,"given":"Victor","family":"Midlej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9498-735X","authenticated-orcid":false,"given":"Eduardo David Soares","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Ant\u00f4nio Ferraz","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adilson David","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1005-278X","authenticated-orcid":false,"given":"Elaine Soares","family":"Coimbra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2022.110333_bib1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2022.110333_bib2","article-title":"Epidemiology of visceral leishmaniasis","volume":"6","author":"Ready","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.cbi.2022.110333_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3201\/eid2512.190164","article-title":"Canine leishmaniasis control in the context of One Health","volume":"25","author":"Dantas-Torres","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.cbi.2022.110333_bib4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/14728222.2018.1472241","article-title":"Emerging therapeutic targets for treatment of leishmaniasis","volume":"22","author":"Sundar","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.cbi.2022.110333_bib5","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1007\/s00253-020-10856-w","article-title":"Recent advances and new strategies on leishmaniasis treatment","volume":"104","author":"Roatt","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.cbi.2022.110333_bib6","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1007\/s40265-013-0133-0","article-title":"Therapeutic options for visceral leishmaniasis","volume":"73","author":"Monge-Maillo","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.cbi.2022.110333_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpddr.2014.02.002","article-title":"Drug repurposing and human parasitic protozoan diseases","volume":"4","author":"Andrews","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.cbi.2022.110333_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135556","article-title":"Antiprotozoal activity profiling of approved drugs: a starting point toward drug repositioning","volume":"10","author":"Kaiser","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2022.110333_bib9","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2741\/4629","article-title":"Leishmaniasis treatment: update of possibilities for drug repurposing","volume":"23","author":"Andrade-Neto","year":"2018","journal-title":"Front. Biosci."},{"key":"10.1016\/j.cbi.2022.110333_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111660","article-title":"Multi-target drugs active against leishmaniasis: a paradigm of drug repurposing","volume":"183","author":"Braga","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2022.110333_bib11","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(02)08348-4","article-title":"Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial","volume":"30","author":"Adjuik","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2022.110333_bib12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bbrc.2016.04.105","article-title":"Anti-inflammatory activity of chloroquine and amodiaquine through p21-mediated suppression of T cell proliferation and Th1 cell differentiation","volume":"474","author":"Oh","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2022.110333_bib13","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/jmv.25031","article-title":"The antimalarial drug amodiaquine possesses anti-ZIKA virus activities","volume":"90","author":"Han","year":"2018","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cbi.2022.110333_bib14","article-title":"Aminoquinolines as translational models for drug repurposing: anticancer adjuvant properties and toxicokinetic-related features","volume":"3","author":"Ferreira","year":"2021","journal-title":"J. Oncol."},{"key":"10.1016\/j.cbi.2022.110333_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.416","article-title":"Lysosomotropism depends on glucose: a chloroquine resistance mechanism","volume":"8","author":"Gallagher","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2022.110333_bib16","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1021\/jm0401006","article-title":"Antileishmanial pyrazol opyridine derivatives: synthesis and structure-activity relationship analysis","volume":"47","author":"De Mello","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2022.110333_bib17","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1016\/j.ejmech.2009.09.012","article-title":"A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and anti plasmodial activity","volume":"44","author":"Guglielmo","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2022.110333_bib18","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/cbdd.12112","article-title":"7-Chloro-4-quinolinyl hydrazones: a promising and potent class of antileishmanial compounds","volume":"81","author":"Coimbra","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.cbi.2022.110333_bib19","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/cbdd.12540","article-title":"4-Aminoquinoline derivatives as potential antileishmanial agentes","volume":"86","author":"Antinarelli","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.cbi.2022.110333_bib20","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s00436-022-07544-1","article-title":"Parasitological and immunological evaluation of a quinoline derivative salt incorporated into a polymeric micelle formulation against Leishmania infantum infection","volume":"121","author":"Ribeiro Antinarelli","year":"2022","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.cbi.2022.110333_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108850","article-title":"Novel functionalized 1,2,3-triazole derivatives exhibit antileishmanial activity, increase in total and mitochondrial-ROS and depolarization of mitochondrial membrane potential of Leishmania amazonensis","volume":"315","author":"Meinel","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2022.110333_bib22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.exppara.2018.10.007","article-title":"Antileishmanial activity of a 4-hydrazinoquinoline derivative: induction of autophagy and apoptosis-related processes and effectiveness in experimental cutaneous leishmaniasis","volume":"195","author":"Antinarelli","year":"2018","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.cbi.2022.110333_bib23","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1111\/jphp.13177","article-title":"Resveratrol analogues present effective antileishmanial activity against promastigotes and amastigotes from distinct Leishmania species by multitarget action in the parasites","volume":"71","author":"Antinarelli","year":"2019","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.cbi.2022.110333_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cbi.2018.08.003","article-title":"Novel organic salts based on quinoline derivatives: the in vitro activity trigger apoptosis inhibiting autophagy in Leishmania spp","volume":"293","author":"Calixto","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2022.110333_bib25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.actatropica.2013.11.003","article-title":"Combination therapy with nitazoxanide and amphotericin B, Glucantime\u00ae, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotes","volume":"130","author":"Mesquita","year":"2014","journal-title":"Acta Trop."},{"key":"10.1016\/j.cbi.2022.110333_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.cbi.2022.110333_bib27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3390\/pathogens11040409","article-title":"The dangerous liaisons in the oxidative stress response to Leishmania infection","volume":"11","author":"Reverte","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.cbi.2022.110333_bib28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpddr.2014.02.002","article-title":"Drug repurposing and human parasitic protozoan diseases","volume":"24","author":"Andrews","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"issue":"9","key":"10.1016\/j.cbi.2022.110333_bib29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3389\/fcimb.2019.00353","article-title":"Sertraline delivered in phosphatidylserine liposomes is effective in an experimental model of visceral leishmaniasis","volume":"29","author":"Romanelli","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.cbi.2022.110333_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0001-706X(01)00197-8","article-title":"Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B","volume":"81","author":"Escobar","year":"2002","journal-title":"Acta Trop."},{"key":"10.1016\/j.cbi.2022.110333_bib31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.3390\/pathogens11040447","article-title":"New vistas in the biology of the flagellum-Leishmania parasites","volume":"11","author":"Landfear","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.cbi.2022.110333_bib32","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760210379","article-title":"Is the mitochondrion a promising drug target in trypanosomatids?","volume":"117","author":"Pedra-Rezende","year":"2022","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.cbi.2022.110333_bib33","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.3390\/ijms19113445","article-title":"Reactive oxygen species induces lipid droplet accumulation in HepG2 cells by increasing perilipin 2 expression","volume":"19","author":"Jin","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2022.110333_bib34","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/cdd.2012.34","article-title":"Apoptosis-induced mitochondrial dysfunction causes cytoplasmic lipid droplet formation","volume":"19","author":"Boren","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cbi.2022.110333_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109690","article-title":"Investigation of the antileishmanial activity and mechanisms of action of acetyl-thiohydantoins","volume":"351","author":"Bortoleti","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2022.110333_bib36","article-title":"Lipid droplets of protozoan parasites: survival and pathogenicity","volume":"116","author":"Tavares","year":"2022","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.cbi.2022.110333_bib37","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00018-015-2104-y","article-title":"Autophagy inhibitors","volume":"73","author":"Pasquier","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cbi.2022.110333_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.biomaterials.2016.12.032","article-title":"Killing colon cancer cells through PCD pathways by a novel hyaluronic acid-modified shell-core nanoparticle loaded with RIP3 in combination with chloroquine","volume":"124","author":"Hou","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.cbi.2022.110333_bib39","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1128\/AAC.00790-10","article-title":"Tafenoquine, an antiplasmodial 8-aminoquinoline, targets Leishmania respiratory complex III and induces apoptosis","volume":"54","author":"Carvalho","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"13","key":"10.1016\/j.cbi.2022.110333_bib40","first-page":"17","article-title":"Adherence to artemisinin-based combination therapy for the treatment of malaria: a systematic review of the evidence","volume":"6","author":"Banek","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.cbi.2022.110333_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01586-16","article-title":"Origins of combination therapy for tuberculosis: lessons for future antimicrobial development and application","volume":"8","author":"Kerantzas","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.cbi.2022.110333_bib42","series-title":"Guidelines for Managing Advanced HIV Disease and Rapid Initiation of Antiretroviral Therapy","year":"2017"},{"issue":"116","key":"10.1016\/j.cbi.2022.110333_bib43","article-title":"Lipid droplets of protozoan parasites: survival and pathogenicity","volume":"16","author":"Sundar","year":"2022","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.cbi.2022.110333_bib44","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.drudis.2016.05.015","article-title":"Drug combination therapy increases successful drug repositioning","volume":"21","author":"Sun","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.cbi.2022.110333_bib45","series-title":"WHO GUIDELINE for the Treatment of Visceral Leishmaniasis in HIV Co-infected Patients in East Africa and South-East Asia","year":"2022"},{"key":"10.1016\/j.cbi.2022.110333_bib46","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev-micro-020518-115546","article-title":"Molecular mechanisms of drug resistance in Plasmodium falciparum malaria","volume":"74","author":"Wicht","year":"2020","journal-title":"Annu. Rev. Microbiol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722005427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722005427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T20:35:42Z","timestamp":1736368542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279722005427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":46,"alternative-id":["S0009279722005427"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110333","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the repositioning of the amodiaquine as potential drug against visceral leishmaniasis: The in vitro effect against Leishmania infantum is associated with multiple mechanisms, involving mitochondria dysfunction, oxidative stress and loss of cell cycle control","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110333"}}